SRZN CIK: 1824893

Surrozen, Inc./DE

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25

Assets

(positive)
Change from FY21 to FY25
millions USD
FY21:
105
FY22:
81.3
FY23:
41.1
FY24:
38.9
FY25:
91.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
32.0
FY22:
8.13
FY23:
4.95
FY24:
9.54
FY25:
7.17
Total assets
Change from FY21 to FY25
millions USD
FY21:
137
FY22:
89.4
FY23:
46.1
FY24:
48.5
FY25:
98.7

Liabilities & Equity

(negative)
Change from FY21 to FY25
millions USD
FY21:
13.6
FY22:
9.73
FY23:
7.15
FY24:
7.32
FY25:
9.93
(negative)
Change from FY21 to FY25
millions USD
FY21:
13.9
FY22:
3.70
FY23:
1.00
FY24:
62.5
FY25:
277
(positive)
Change from FY21 to FY25
millions USD
FY21:
110
FY22:
76.0
FY23:
37.9
FY24:
−21.4
FY25:
−188
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
137
FY22:
89.4
FY23:
46.1
FY24:
48.5
FY25:
98.7

All amounts in millions USD Data source:SEC EDGAR